bryostatin 1 (NSC 339555) / Blanchette Rockefeller Neurosciences Institute, Synaptogenix 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bryostatin 1 (NSC 339555) / Synaptogenix
NCT04538066: Bryostatin Treatment of Moderately Severe Alzheimer's Disease

Completed
2
122
US
Bryostatin 1, Placebo
Neurotrope Bioscience, Inc., National Institutes of Health (NIH), National Institute on Aging (NIA)
Alzheimer Disease
11/22
11/22
NCT06190912: Safety of Bryostatin in Patients With MS

Recruiting
1
20
US
Bryostatin 1
Robert Fox, Synaptogenix, Inc.
Multiple Sclerosis
04/26
08/26

Download Options